- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07943507
Clinical, Radiographic and Histological Evaluation of the Efficacy of Oxygen-Releasing Oral Gel in Enhancing Tissue Healing Following Extraction
Clinical, Radiographic and Histological Evaluation of the Efficacy of Oxygen-Releasing Oral Gel in Enhancing Tissue Healing Following Extraction :A Randomized Comparative Study
Clinical, Radiographic and Histological Evaluation of the Efficacy of Oxygen-Releasing Oral Gel in Enhancing Tissue Healing Following Extraction :A Randomized Comparative Study
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
Wound healing presents significant clinical challenges, particularly among immunocompromised individuals and patients suffering from chronic systemic conditions such as diabetes. These patient groups are more prone to postoperative complications and frequently experience delayed healing processes. Under normal physiological conditions, wound healing follows a cascade that heavily depends on the formation of granulation tissue, where blood vessels play a crucial role. As the healing tissue matures, the density of these vessels diminishes. However, in diabetic individuals, impaired immune responses and defective neovascularization significantly hinder this process. Interestingly, the oral mucosa demonstrates a unique healing pattern-characterized by a reduced vascular response yet more mature and efficient capillaries. This feature promotes enhanced oxygen delivery to regenerating tissues and contributes to faster healing. A key factor impeding effective wound healing is insufficient tissue oxygenation, often caused by compromised vascular supply. This deficiency adversely affects leukocyte-mediated bacterial clearance and tissue regeneration. Oxygen is vital not only for cellular repair mechanisms but also for its antimicrobial effects, particularly through oxidative microbial destruction.
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
Egypt
-
Ismailia, Egypt, Ägypten
- Faculty of dentistry Suez canal university
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
-
Age ≥ 18 years (able to sign informed consent).
-
Requires extraction of at least one hopeless tooth meeting one or more of the following:
- Furcation involvement > Class II -Tooth mobility > Grade II
- Probing pocket depth (PPD) > 6 mm
- Alveolar bone loss ≥ 70% of root length
- Persistent radiographic pathology or chronic symptoms (e.g., pain, fistula, infection)
- Non-restorable condition
-
The case can be prepared for implant placement
Exclusion Criteria:
- General contraindications to surgery
- Pregnancy or breastfeeding
- Uncontrolled diabetes
- Current or previous intravenous bisphosphonate therapy
- History of allergic reaction to the applied gel or any of its components
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Study with BlueM gel
BlueM oxygen releasing oral gel will be applied topically on the extraction site immediately after the procedure. |
BlueM oxygen releasing oral gel will be applied topically on the extraction site immediately after the procedure standard postoperative care without the use of the gel, allowing for natural healing |
|
Placebo-Komparator: Control without BlueM gel
Standard postoperative care without the use of the gel, allowing for natural healing. |
BlueM oxygen releasing oral gel will be applied topically on the extraction site immediately after the procedure standard postoperative care without the use of the gel, allowing for natural healing |
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Post-operative pain
Zeitfenster: 1, 3 and 7 days
|
Post-operative pain levels assessed using the Visual Analog Scale (VAS), where higher scores indicate worse outcomes (more pain). Minimum score = 0 (No pain); Maximum score = 10 (Severe pain that completely prevents daily activities). |
1, 3 and 7 days
|
|
post-operative complications
Zeitfenster: 1, 3 and 7 days
|
Measure the incidence of post-operative complications (e.g., dry socket, infection) in both groups. |
1, 3 and 7 days
|
|
Clinical signs of inflammation
Zeitfenster: 1, 3 and 7 days
|
Clinical signs of inflammation assessed using an ordinal clinical grading scale for swelling, where higher scores indicate worse outcomes (more severe inflammation). Scale ranges from 1 to 4: 1 = none (no visible swelling), 2 = mild (intraoral swelling in the surgical zone), 3 = moderate (extraoral swelling in the surgical zone), and 4 = severe (extraoral swelling extending beyond the surgical zone and visible hematoma and ecchymosis). |
1, 3 and 7 days
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Changes in Bone Density and Vertical Bone Height Assessed by Cone-Beam Computed Tomography (CBCT)
Zeitfenster: Immediately and 6 months post-operatively
|
Assessment of bone regeneration promoted by the oxygen-releasing oral gel. Vertical bone height will be measured in millimeters (mm) and bone density will be evaluated using CBCT scans immediately and 6 months post-operatively. |
Immediately and 6 months post-operatively
|
|
Histomorphometric Analysis of Bone Quality Using H&E and Masson's Trichrome Staining
Zeitfenster: 6 months post-operatively
|
Assessment of bone quality evaluated by histomorphometric analysis of tissue sections stained with Hematoxylin and Eosin (H&E) and Masson's Trichrome. The measurement quantifies the distribution and number of osteoblasts and osteocytes, as well as the maturation of bone (differentiating between woven and lamellar bone) at 6 months post-operatively. Higher maturation of lamellar bone and balanced cellular distribution indicate better outcomes. |
6 months post-operatively
|
Mitarbeiter und Ermittler
Sponsor
Publikationen und hilfreiche Links
Allgemeine Veröffentlichungen
- Rodriguez PG, Felix FN, Woodley DT, Shim EK. The role of oxygen in wound healing: a review of the literature. Dermatol Surg. 2008 Sep;34(9):1159-69. doi: 10.1111/j.1524-4725.2008.34254.x. Epub 2008 May 29.
- Alshehri, F.A., 2023. Role of Topical Oxygen Oral Therapy in Wound Healing of Oral and Periodontal Tissues: A Narrative Review. Pakistan Oral & Dental Journal, 43(3), pp.106-113.
- Lindholm C, Searle R. Wound management for the 21st century: combining effectiveness and efficiency. Int Wound J. 2016 Jul;13 Suppl 2(Suppl 2):5-15. doi: 10.1111/iwj.12623.
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Tatsächlich)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Andere Studien-ID-Nummern
- 2025/1005
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .